An oral anti cancer drug. Works by inhibiting cellular signals by targeting multiple receptor tyrosine kinases (RTKs). Sunitinib is approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) Reference standards of Sunitinib API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => 5-((Z)-(5-Fluoro-2-oxoindolin-3-ylidene)methyl)-2,4-dimethyl-1h-pyrrole-3-carboxylic acid (BSC) [catalogue_number] => PA BSC 07519410 [category_ids] => ,169, [chemical_name] => [weight] => 300.29 [form] => C16H13FN2O3 [cas] => 356068-93-4 [pslug] => 356068-93-4-5-z-5-fluoro-2-oxoindolin-3-ylidene-methyl-2-4-dimethyl-1h-pyrrole-3-carboxylic-acid-bsc-pabsc07519410 [latest_product] => 0 [linkproducts] => 0 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA BSC 07519410
CAS :
Molecular Formula : C16H13FN2O3
Molecular Weight : 300.29
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
